La Lingua Nostra La Lingua Nostra
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Postari
  • Articles
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • ROHIT GAURYA a adăugat un fișier Health
    2026-03-31 10:29:12 -
    GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%
    According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...
    0 Commentarii 0 Distribuiri 217 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Komal Galande a adăugat un fișier Health
    2026-04-22 05:46:48 -
    Is the EPO Drugs Market Expanding with Advancements in Anemia Treatment?
    Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...
    0 Commentarii 0 Distribuiri 7 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • ROHIT GAURYA a adăugat un fișier Health
    2026-04-06 12:37:37 -
    Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
    According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...
    0 Commentarii 0 Distribuiri 176 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 La Lingua Nostra Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne